title: Microbiome alterations in HIV infection a review.
abstract: Recent developments in molecular techniques have allowed researchers to identify previously uncultured organisms, which has propelled a vast expansion of our knowledge regarding our commensal microbiota. Interest in the microbiome specific to HIV grew from earlier findings suggesting that bacterial translocation from the intestines is the cause of persistent immune activation despite effective viral suppression with antiretroviral therapy (ART). Studies of SIV infected primates have demonstrated that Proteobacteria preferentially translocate and that mucosal immunity can be restored with probiotics. Pathogenic SIV infection results in a massive expansion of the virome, whereas non-pathogenic SIV infection does not. Human HIV infected cohorts have been shown to have microbiota distinctive from that of HIV negative controls and efforts to restore the intestinal microbiome via probiotics have often had positive results on host markers. The microbiota of the genital tract may play a significant role in acquisition and transmission of HIV. Modification of commensal microbial communities likely represents an important therapeutic adjunct to treatment of HIV. Here we review the literature regarding human microbiome in HIV infection.
authors.affiliation: Division of Infectious Diseases, Rush University Medical Center, USA.
authors.forename: Brett
authors.initials: B
authors.lastname: Williams
authors.affiliation: Department of Immunology/microbiology, Rush University Medical Center, USA.
authors.forename: Alan
authors.initials: A
authors.lastname: Landay
authors.affiliation: Division of Infectious Disease, Washington University School of Medicine, USA.
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Presti
mesh_terms: D018988:Bacterial Translocation / Q000235:genetics; D006678:HIV / Q000235:genetics / Q000472:pathogenicity; D015658:HIV Infections / Q000235:genetics / Q000382:microbiology* / Q000821:virology; D054884:Host-Pathogen Interactions / Q000235:genetics; D006801:Humans; D007413:Intestinal Mucosa / Q000382:microbiology* / Q000821:virology; D007422:Intestines / Q000382:microbiology* / Q000821:virology; D064307:Microbiota / Q000235:genetics*; D019936:Probiotics / Q000627:therapeutic use; D060737:Reproductive Tract Infections / Q000382:microbiology / Q000821:virology